0001628280-24-004111.txt : 20240209
0001628280-24-004111.hdr.sgml : 20240209
20240209170245
ACCESSION NUMBER: 0001628280-24-004111
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240207
FILED AS OF DATE: 20240209
DATE AS OF CHANGE: 20240209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nouri Alaleh
CENTRAL INDEX KEY: 0001599418
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40797
FILM NUMBER: 24615969
MAIL ADDRESS:
STREET 1: 1310 CHESAPEAKE TERRACE
CITY: SUNNYVALE
STATE: CA
ZIP: 94089
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROCEPT BioRobotics Corp
CENTRAL INDEX KEY: 0001588978
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 260199180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 BAYTECH DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 6502329832
MAIL ADDRESS:
STREET 1: 150 BAYTECH DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
4
1
wk-form4_1707516153.xml
FORM 4
X0508
4
2024-02-07
0
0001588978
PROCEPT BioRobotics Corp
PRCT
0001599418
Nouri Alaleh
C/O PROCEPT BIOROBOTICS CORPORATION
150 BAYTECH DRIVE
SAN JOSE
CA
95134
0
1
0
0
EVP, CLO, CORP. SEC.
1
Common Stock
2024-02-07
4
M
0
5306
5.18
A
52657
D
Common Stock
2024-02-07
4
S
0
5306
49.9535
D
47351
D
Common Stock
2024-02-09
4
M
0
14694
5.18
A
62045
D
Common Stock
2024-02-09
4
S
0
14694
49.9737
D
47351
D
Stock Option (Right to Buy)
5.18
2024-02-07
4
M
0
5306
0
D
2030-08-08
Common Stock
5306
34819
D
Stock Option (Right to Buy)
5.18
2024-02-09
4
M
0
14694
0
D
2030-08-08
Common Stock
14694
20125
D
All transactions reported here were affected pursuant to Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.95 to $50.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.95 to $50.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The Stock option was granted on August 10, 2020 and vested 12.5% on the six month anniversary of August 1, 2020 and the remainder on each monthly anniversary over a three and a half year period, subject continued employment or service to the Issuer through the applicable vesting date.
/s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri
2024-02-09